
Nuvation Bio Investor Relations Material
Latest events

FDA Announcement
Nuvation Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nuvation Bio Inc
Access all reports
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company dedicated to addressing some of the most significant unmet needs in oncology. The company is focused on the development of differentiated and novel therapeutic candidates, aiming to significantly change the practice of oncology through medicines that offer meaningful improvements in quality of life and survival for cancer patients. Nuvation Bio's approach includes a wholly-owned deep pipeline of six differentiated and novel investigational oncology therapeutic candidates targeting critical pathways that cancer cells use for growth. The company is headquartered in New York, New York, and its shares are listed on the NYSE.
Key slides for Nuvation Bio Inc


TD Cowen 45th Annual Healthcare Conference
Nuvation Bio Inc


TD Cowen 45th Annual Healthcare Conference
Nuvation Bio Inc
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
NUVB
Country
🇺🇸 United States